Cue Biopharma Quote - CUE

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.08

Bid

0.98

Ask

1.15

Volume

257,260

1.0203 Day's Range 1.10

0.45 52 Week Range 3.20

Market Cap

68.418M

Previous Close

1.01

Open

1.03

Last Trade

4746

1.08

Last Trade Time

15:00:00

Financial Volume

US$ 275,680

VWAP

1.0716

Average Volume (3m)

747,357

Shares Outstanding

63,350,327

Dividend Yield

PE Ratio

-1.35

Earnings Per Share (EPS)

-0.8

Revenue

5.49M

Net Profit

-50.73M

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cuebiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Cue Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CUE. The last closing price for Cue Biopharma was US$1.01. Over the last year, Cue Biopharma shares have traded in a share price range of US$ 0.45 to US$ 3.20.

Cue Biopharma currently has 63,350,327 shares outstanding. The market capitalization of Cue Biopharma is US$63.98 million. Cue Biopharma has a price to earnings ratio (PE ratio) of -1.35.

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

Objective response rate (ORR) of 46%, 12-month overall survival (OS) of 91.3% and a median overall survival (mOS) of 21.8 months in first line (1L) HPV+ R/M HNSCC patients treated with CUE-101 and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0363	-3.25181402849	1.1163	1.14	0.98	308161	1.017323	CS
4	-0.16	-12.9032258065	1.24	1.27	0.92	305347	1.06087088	CS
12	0.3768	53.5836177474	0.7032	1.9891	0.7032	747357	1.36003601	CS
26	-0.39	-26.5306122449	1.47	1.9891	0.45	604851	1.12993261	CS
52	-1.9	-63.7583892617	2.98	3.2	0.45	444475	1.4254581	CS
156	-11.53	-91.435368755	12.61	12.79	0.45	359255	3.01454172	CS
260	-16.17	-93.7391304348	17.25	35.5	0.45	337946	7.73188889	CS

CUE - Frequently Asked Questions (FAQ)

What is the current Cue Biopharma share price?

The current share price of Cue Biopharma is US$ 1.08

How many Cue Biopharma shares are in issue?

Cue Biopharma has 63,350,327 shares in issue

What is the market cap of Cue Biopharma?

The market capitalisation of Cue Biopharma is USD 63.98M

What is the 1 year trading range for Cue Biopharma share price?

Cue Biopharma has traded in the range of US$ 0.45 to US$ 3.20 during the past year

What is the PE ratio of Cue Biopharma?

The price to earnings ratio of Cue Biopharma is -1.35

What is the cash to sales ratio of Cue Biopharma?

The cash to sales ratio of Cue Biopharma is 12.46

What is the reporting currency for Cue Biopharma?

Cue Biopharma reports financial results in USD

What is the latest annual turnover for Cue Biopharma?

The latest annual turnover of Cue Biopharma is USD 5.49M

What is the latest annual profit for Cue Biopharma?

The latest annual profit of Cue Biopharma is USD -50.73M

What is the registered address of Cue Biopharma?

The registered address for Cue Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Cue Biopharma website address?

The website address for Cue Biopharma is www.cuebiopharma.com

Which industry sector does Cue Biopharma operate in?

Cue Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EVAXEvaxion Biotech AS	US$ 1.62 (91.49%)	6.86M
INTZIntrusion Inc	US$ 0.8186 (81.91%)	2.69M
LIDRAEye Inc	US$ 1.93 (50.78%)	2.05M
JSPRWJasper Therapeutics Inc	US$ 0.25 (47.06%)	343
RVSNRail Vision Ltd	US$ 1.11 (43.49%)	5.08M
MITAColiseum Acquisition Corporation	US$ 9.00 (-21.81%)	11.78k
VIRXViracta Therapeutics Inc	US$ 0.195 (-17.72%)	350.42k
LGCBLinkage Global Inc	US$ 0.39 (-14.66%)	35.31k
SLGLSol Gel Technologies Ltd	US$ 1.06 (-13.11%)	31.67k
XELBXcel Brands Inc	US$ 0.4576 (-11.81%)	37.45k
CRKNCrown Electrokinetics Corporation	US$ 0.1786 (35.61%)	29.42M
OMEXOdyssey Marine Exploration Inc	US$ 0.6078 (26.49%)	9.48M
EVAXEvaxion Biotech AS	US$ 1.62 (91.49%)	6.86M
KITTNauticus Robotics Inc	US$ 2.25 (26.40%)	5.22M
RVSNRail Vision Ltd	US$ 1.11 (43.49%)	5.08M